A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours
Clinical trial NCT03658070 · UNKNOWN
Trial details
- NCT number
- NCT03658070
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2020-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.